Phase 3
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Pancreatic Cancer
Both
Pancreatic Cancer
Trial Information
Inclusion Criteria
Inclusion criteria:
- Clinical diagnosis of pancreatic adenocarcinoma
- Life expectancy of at least 3 months
- Functional status by Karnofsky Index of at least 70
Exclusion criteria:
- Prior treatment with chemotherapy, radiotherapy, or anti-cancer immunotherapy
- Chronic use of corticosteroids, except for inhaled corticosteroids used for asthma or
chronic obstructive pulmonary disease
- Immunodeficiency
- Bone marrow transplant within past year
- Brain metastasis
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
PC4
NCT ID:
NCT00044031
Start Date:
February 2001
Completion Date:
Related Keywords:
- Pancreatic Cancer
- Pancreatic Neoplasms
Name | Location |
|---|
